Source: Pharmaceuticals. Unidade: IFSC
Subjects: ZIKA VÍRUS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA MÉDICA
ABNT
RAMOS, Paulo Ricardo Pimenta da Silva et al. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches. Pharmaceuticals, v. 15, n. 12, p. 1493-1-1493-17, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15121493. Acesso em: 18 nov. 2024.APA
Ramos, P. R. P. da S., Mottin, M., Lima, C. S., Assis, L. R., Oliveira, K. Z. de, Mesquita, N. C. de M. R., et al. (2022). Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches. Pharmaceuticals, 15( 12), 1493-1-1493-17. doi:10.3390/ph15121493NLM
Ramos PRP da S, Mottin M, Lima CS, Assis LR, Oliveira KZ de, Mesquita NC de MR, Cassani NM, Santos IA, Borba JVVB, Costa VAF, Junior Neves B, Guido RVC, Oliva G, Jardim ACG, Regasini LO, Andrade CH. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches [Internet]. Pharmaceuticals. 2022 ; 15( 12): 1493-1-1493-17.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ph15121493Vancouver
Ramos PRP da S, Mottin M, Lima CS, Assis LR, Oliveira KZ de, Mesquita NC de MR, Cassani NM, Santos IA, Borba JVVB, Costa VAF, Junior Neves B, Guido RVC, Oliva G, Jardim ACG, Regasini LO, Andrade CH. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches [Internet]. Pharmaceuticals. 2022 ; 15( 12): 1493-1-1493-17.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ph15121493